| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 40 | 2024 | 2102 | 5.880 |
Why?
|
| Radiology Department, Hospital | 15 | 2021 | 405 | 4.820 |
Why?
|
| Quality Assurance, Health Care | 21 | 2015 | 2176 | 2.440 |
Why?
|
| Diagnostic Errors | 10 | 2024 | 1266 | 2.200 |
Why?
|
| Peer Review | 7 | 2020 | 218 | 2.140 |
Why?
|
| Burnout, Professional | 4 | 2023 | 702 | 1.570 |
Why?
|
| Quality Improvement | 11 | 2018 | 3836 | 1.350 |
Why?
|
| Employee Performance Appraisal | 3 | 2018 | 86 | 1.130 |
Why?
|
| Leadership | 6 | 2020 | 1371 | 1.120 |
Why?
|
| Professional Practice | 3 | 2018 | 313 | 1.000 |
Why?
|
| Practice Management, Medical | 2 | 2018 | 191 | 0.980 |
Why?
|
| Job Satisfaction | 2 | 2018 | 539 | 0.960 |
Why?
|
| Tomography, X-Ray Computed | 50 | 2012 | 20509 | 0.920 |
Why?
|
| Risk Management | 6 | 2015 | 558 | 0.890 |
Why?
|
| Interprofessional Relations | 3 | 2021 | 989 | 0.800 |
Why?
|
| Medical Errors | 8 | 2021 | 1255 | 0.800 |
Why?
|
| Liver Neoplasms | 22 | 2009 | 4319 | 0.790 |
Why?
|
| Liver Circulation | 7 | 2004 | 159 | 0.760 |
Why?
|
| Diagnostic Imaging | 10 | 2017 | 3527 | 0.760 |
Why?
|
| Radiography, Abdominal | 4 | 2023 | 532 | 0.750 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 4 | 2018 | 92 | 0.730 |
Why?
|
| Liver | 24 | 2007 | 7509 | 0.720 |
Why?
|
| Credentialing | 3 | 2018 | 115 | 0.640 |
Why?
|
| Radiology, Interventional | 3 | 2022 | 475 | 0.640 |
Why?
|
| Safety Management | 5 | 2015 | 760 | 0.630 |
Why?
|
| Peer Review, Health Care | 2 | 2016 | 73 | 0.630 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 1416 | 0.620 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2008 | 507 | 0.610 |
Why?
|
| Ultrasonography | 20 | 2011 | 5961 | 0.600 |
Why?
|
| Database Management Systems | 2 | 2017 | 258 | 0.580 |
Why?
|
| Contrast Media | 17 | 2011 | 5305 | 0.560 |
Why?
|
| Clinical Competence | 6 | 2017 | 4783 | 0.560 |
Why?
|
| Checklist | 2 | 2022 | 827 | 0.550 |
Why?
|
| Health Promotion | 2 | 2018 | 2206 | 0.540 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 726 | 0.540 |
Why?
|
| Colonography, Computed Tomographic | 7 | 2009 | 169 | 0.530 |
Why?
|
| Models, Organizational | 4 | 2015 | 545 | 0.520 |
Why?
|
| Organizational Objectives | 3 | 2015 | 428 | 0.510 |
Why?
|
| Radiology Information Systems | 4 | 2017 | 528 | 0.510 |
Why?
|
| Ultrasonography, Interventional | 10 | 2009 | 1502 | 0.510 |
Why?
|
| Radiography | 7 | 2020 | 6965 | 0.510 |
Why?
|
| Angiography | 8 | 2008 | 1605 | 0.490 |
Why?
|
| Catheter Ablation | 16 | 2006 | 2758 | 0.470 |
Why?
|
| Episode of Care | 1 | 2015 | 127 | 0.470 |
Why?
|
| Cultural Diversity | 1 | 2018 | 365 | 0.460 |
Why?
|
| Rectal Diseases | 2 | 2008 | 144 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 4 | 2008 | 2640 | 0.450 |
Why?
|
| Oxides | 4 | 2008 | 401 | 0.440 |
Why?
|
| Doxorubicin | 9 | 2003 | 2209 | 0.440 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 696 | 0.420 |
Why?
|
| Living Donors | 9 | 2008 | 636 | 0.420 |
Why?
|
| Liver Transplantation | 16 | 2008 | 2325 | 0.410 |
Why?
|
| Cholecystitis, Acute | 2 | 2011 | 74 | 0.410 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2000 | 190 | 0.400 |
Why?
|
| Humans | 151 | 2024 | 760621 | 0.390 |
Why?
|
| United States | 26 | 2023 | 72461 | 0.380 |
Why?
|
| Radiographic Image Enhancement | 5 | 2007 | 875 | 0.380 |
Why?
|
| Minority Groups | 1 | 2018 | 1201 | 0.370 |
Why?
|
| Writing | 1 | 2013 | 199 | 0.370 |
Why?
|
| Organizational Culture | 3 | 2020 | 506 | 0.360 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 697 | 0.350 |
Why?
|
| Hepatectomy | 6 | 2006 | 559 | 0.340 |
Why?
|
| Emotions | 1 | 2021 | 2734 | 0.340 |
Why?
|
| Abdominal Neoplasms | 3 | 2008 | 286 | 0.340 |
Why?
|
| Occupational Health | 2 | 2013 | 805 | 0.330 |
Why?
|
| Intraoperative Care | 4 | 2006 | 768 | 0.330 |
Why?
|
| Image Enhancement | 5 | 2008 | 2881 | 0.330 |
Why?
|
| Defecography | 1 | 2008 | 17 | 0.330 |
Why?
|
| Electronic Mail | 1 | 2010 | 213 | 0.320 |
Why?
|
| Health Care Reform | 2 | 2015 | 1245 | 0.320 |
Why?
|
| Anus Diseases | 1 | 2008 | 55 | 0.320 |
Why?
|
| Quality Indicators, Health Care | 2 | 2017 | 1824 | 0.310 |
Why?
|
| Adnexal Diseases | 1 | 2009 | 106 | 0.300 |
Why?
|
| Appendicitis | 2 | 2006 | 674 | 0.300 |
Why?
|
| Colorectal Neoplasms | 11 | 2007 | 6853 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 7 | 2012 | 7475 | 0.300 |
Why?
|
| Data Collection | 2 | 2014 | 3315 | 0.290 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2008 | 2049 | 0.290 |
Why?
|
| Adenocarcinoma | 8 | 2007 | 6315 | 0.290 |
Why?
|
| Endosonography | 3 | 2010 | 607 | 0.290 |
Why?
|
| Workflow | 1 | 2012 | 852 | 0.280 |
Why?
|
| Publishing | 2 | 2014 | 836 | 0.280 |
Why?
|
| Cognition | 1 | 2024 | 6957 | 0.270 |
Why?
|
| Halothane | 4 | 2004 | 200 | 0.270 |
Why?
|
| Accreditation | 2 | 2011 | 477 | 0.270 |
Why?
|
| Cholecystostomy | 2 | 2004 | 48 | 0.270 |
Why?
|
| Documentation | 1 | 2013 | 893 | 0.270 |
Why?
|
| Societies, Medical | 6 | 2023 | 3905 | 0.270 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1392 | 0.270 |
Why?
|
| Iron | 3 | 2008 | 1786 | 0.270 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 241 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2007 | 8950 | 0.260 |
Why?
|
| Online Systems | 1 | 2006 | 181 | 0.260 |
Why?
|
| Colitis, Ischemic | 1 | 2005 | 32 | 0.260 |
Why?
|
| Osteomyelitis | 2 | 2008 | 407 | 0.250 |
Why?
|
| Cholecystitis | 2 | 2004 | 181 | 0.250 |
Why?
|
| Appendix | 1 | 2006 | 110 | 0.250 |
Why?
|
| Teleradiology | 1 | 2005 | 53 | 0.250 |
Why?
|
| Faculty, Medical | 1 | 2013 | 1192 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 544 | 0.250 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2010 | 1008 | 0.240 |
Why?
|
| Workplace | 3 | 2020 | 857 | 0.240 |
Why?
|
| Quality of Health Care | 2 | 2018 | 4360 | 0.240 |
Why?
|
| Colonic Polyps | 5 | 2003 | 551 | 0.240 |
Why?
|
| Radiography, Interventional | 5 | 2006 | 1114 | 0.240 |
Why?
|
| Occupational Diseases | 1 | 2013 | 1486 | 0.240 |
Why?
|
| Information Dissemination | 1 | 2013 | 1131 | 0.230 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3448 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2010 | 36290 | 0.230 |
Why?
|
| Hepatic Artery | 7 | 2004 | 230 | 0.230 |
Why?
|
| Liver Diseases | 7 | 2009 | 1302 | 0.230 |
Why?
|
| Constipation | 1 | 2008 | 561 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 6 | 2007 | 5351 | 0.220 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2007 | 508 | 0.220 |
Why?
|
| Colonic Diseases | 2 | 2007 | 200 | 0.220 |
Why?
|
| Hepatic Veins | 6 | 2004 | 112 | 0.220 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2007 | 471 | 0.220 |
Why?
|
| Biliary Tract | 2 | 2001 | 135 | 0.210 |
Why?
|
| Ultrasonography, Doppler | 3 | 2008 | 465 | 0.210 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 231 | 0.210 |
Why?
|
| Preoperative Care | 7 | 2007 | 2256 | 0.210 |
Why?
|
| Microscopy, Fluorescence | 6 | 2007 | 2651 | 0.210 |
Why?
|
| Internship and Residency | 4 | 2013 | 5870 | 0.210 |
Why?
|
| X-Rays | 1 | 2023 | 307 | 0.210 |
Why?
|
| Forecasting | 4 | 2023 | 2932 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2013 | 1809 | 0.200 |
Why?
|
| Pancreatectomy | 2 | 2021 | 810 | 0.200 |
Why?
|
| Theft | 1 | 2021 | 20 | 0.200 |
Why?
|
| Hemangiopericytoma | 1 | 2002 | 71 | 0.200 |
Why?
|
| Antigens | 5 | 1992 | 1447 | 0.200 |
Why?
|
| Spinal Diseases | 1 | 2007 | 559 | 0.200 |
Why?
|
| Colonoscopy | 5 | 2007 | 1387 | 0.190 |
Why?
|
| User-Computer Interface | 6 | 2007 | 1403 | 0.190 |
Why?
|
| Rectal Neoplasms | 3 | 2002 | 1152 | 0.190 |
Why?
|
| Rectal Fistula | 1 | 2001 | 75 | 0.190 |
Why?
|
| Running | 1 | 2005 | 483 | 0.180 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2002 | 155 | 0.180 |
Why?
|
| Brain Diseases | 2 | 2007 | 1540 | 0.180 |
Why?
|
| Internet | 5 | 2021 | 3078 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3865 | 0.180 |
Why?
|
| Mice, Nude | 9 | 2007 | 3607 | 0.180 |
Why?
|
| Microscopy, Video | 6 | 2004 | 242 | 0.180 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 5325 | 0.170 |
Why?
|
| Bile Ducts | 1 | 2001 | 282 | 0.170 |
Why?
|
| Portal Vein | 8 | 2004 | 429 | 0.170 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 5 | 1992 | 418 | 0.170 |
Why?
|
| Certification | 2 | 2015 | 421 | 0.170 |
Why?
|
| Communication | 2 | 2012 | 3849 | 0.170 |
Why?
|
| Venereal Tumors, Veterinary | 3 | 2004 | 8 | 0.170 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2006 | 698 | 0.170 |
Why?
|
| Privacy | 1 | 2021 | 233 | 0.170 |
Why?
|
| Referral and Consultation | 3 | 2010 | 3598 | 0.170 |
Why?
|
| Chest Pain | 1 | 2006 | 1106 | 0.160 |
Why?
|
| Chemoembolization, Therapeutic | 3 | 1996 | 127 | 0.160 |
Why?
|
| Group Processes | 1 | 2020 | 226 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2006 | 2299 | 0.160 |
Why?
|
| Male | 74 | 2021 | 359744 | 0.160 |
Why?
|
| Adenomatous Polyps | 1 | 1999 | 108 | 0.150 |
Why?
|
| Portal Pressure | 1 | 1998 | 60 | 0.150 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 732 | 0.150 |
Why?
|
| Sensitivity and Specificity | 14 | 2009 | 14660 | 0.150 |
Why?
|
| Patient Selection | 5 | 2007 | 4283 | 0.150 |
Why?
|
| Rats, Inbred F344 | 6 | 2007 | 825 | 0.140 |
Why?
|
| Female | 69 | 2021 | 391270 | 0.140 |
Why?
|
| Research Report | 1 | 2020 | 370 | 0.140 |
Why?
|
| Blood Flow Velocity | 3 | 2007 | 1377 | 0.140 |
Why?
|
| Feedback, Psychological | 1 | 2017 | 95 | 0.140 |
Why?
|
| Rectum | 3 | 2002 | 895 | 0.140 |
Why?
|
| Patient Access to Records | 1 | 2018 | 119 | 0.140 |
Why?
|
| Pandemics | 3 | 2021 | 8624 | 0.130 |
Why?
|
| Equipment Design | 6 | 2008 | 3520 | 0.130 |
Why?
|
| Choristoma | 2 | 2010 | 207 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2000 | 434 | 0.130 |
Why?
|
| Pelvis | 2 | 2014 | 743 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2007 | 18137 | 0.130 |
Why?
|
| Ferrosoferric Oxide | 3 | 2008 | 348 | 0.130 |
Why?
|
| Education, Medical, Continuing | 1 | 2021 | 830 | 0.130 |
Why?
|
| Antineoplastic Agents | 8 | 2008 | 13630 | 0.130 |
Why?
|
| Biliary Tract Neoplasms | 1 | 1997 | 184 | 0.120 |
Why?
|
| Data Display | 3 | 2012 | 174 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2002 | 888 | 0.120 |
Why?
|
| Colonic Neoplasms | 4 | 2012 | 2526 | 0.120 |
Why?
|
| Rats | 18 | 2008 | 23711 | 0.120 |
Why?
|
| Animals | 42 | 2008 | 167963 | 0.120 |
Why?
|
| Professional Competence | 2 | 2009 | 431 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 2363 | 0.120 |
Why?
|
| Neoplasm Transplantation | 6 | 2004 | 2014 | 0.120 |
Why?
|
| Granuloma, Plasma Cell | 2 | 2009 | 80 | 0.120 |
Why?
|
| Anesthetics, Inhalation | 2 | 2004 | 574 | 0.110 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 3242 | 0.110 |
Why?
|
| Pancreatic Diseases | 2 | 2010 | 343 | 0.110 |
Why?
|
| Acute Disease | 4 | 2006 | 7269 | 0.110 |
Why?
|
| Daunorubicin | 1 | 1993 | 156 | 0.110 |
Why?
|
| Specialty Boards | 1 | 2015 | 235 | 0.110 |
Why?
|
| Spinal Cord Diseases | 2 | 2007 | 293 | 0.110 |
Why?
|
| Pancreas | 2 | 2010 | 1677 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 544 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2008 | 948 | 0.110 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2013 | 54 | 0.110 |
Why?
|
| Risk Assessment | 7 | 2020 | 24123 | 0.110 |
Why?
|
| Adult | 45 | 2021 | 219994 | 0.110 |
Why?
|
| Fibrin | 4 | 1993 | 505 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 2 | 2006 | 273 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2006 | 6414 | 0.100 |
Why?
|
| Rabbits | 4 | 2008 | 4773 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2543 | 0.100 |
Why?
|
| Needlestick Injuries | 1 | 2013 | 71 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
| Cost Control | 1 | 2015 | 630 | 0.100 |
Why?
|
| Radiation Dosage | 3 | 2013 | 1958 | 0.100 |
Why?
|
| Middle Aged | 45 | 2021 | 220352 | 0.100 |
Why?
|
| Aged, 80 and over | 22 | 2014 | 58995 | 0.100 |
Why?
|
| Necrosis | 5 | 2004 | 1612 | 0.100 |
Why?
|
| Abdominal Abscess | 2 | 2006 | 152 | 0.100 |
Why?
|
| Retrospective Studies | 16 | 2021 | 80372 | 0.100 |
Why?
|
| Barium Sulfate | 3 | 2008 | 180 | 0.100 |
Why?
|
| Remedial Teaching | 1 | 2011 | 16 | 0.100 |
Why?
|
| Private Sector | 1 | 2015 | 397 | 0.100 |
Why?
|
| Eledoisin | 1 | 1991 | 2 | 0.100 |
Why?
|
| Software Design | 1 | 2012 | 171 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1995 | 317 | 0.100 |
Why?
|
| Neurokinin A | 1 | 1991 | 32 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2003 | 675 | 0.100 |
Why?
|
| Aged | 35 | 2021 | 169152 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2852 | 0.090 |
Why?
|
| Product Labeling | 1 | 2012 | 77 | 0.090 |
Why?
|
| Neoplasms | 4 | 2012 | 22072 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2002 | 114 | 0.090 |
Why?
|
| Kidney Neoplasms | 3 | 2004 | 4312 | 0.090 |
Why?
|
| Amino Acids, Essential | 1 | 1991 | 26 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2007 | 516 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 2 | 2008 | 316 | 0.090 |
Why?
|
| Biopsy, Needle | 2 | 2009 | 1630 | 0.090 |
Why?
|
| Ethiodized Oil | 3 | 1996 | 25 | 0.090 |
Why?
|
| Dextrans | 2 | 2008 | 574 | 0.090 |
Why?
|
| Neurokinin B | 1 | 1991 | 67 | 0.090 |
Why?
|
| Observer Variation | 3 | 2009 | 2601 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1992 | 1744 | 0.090 |
Why?
|
| Neoplasm Staging | 5 | 2007 | 11152 | 0.090 |
Why?
|
| Boston | 3 | 2013 | 9280 | 0.090 |
Why?
|
| Substance P | 1 | 1991 | 333 | 0.090 |
Why?
|
| Software | 5 | 2007 | 4419 | 0.090 |
Why?
|
| Biliary Tract Diseases | 2 | 2001 | 157 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2435 | 0.080 |
Why?
|
| Patient Care Team | 2 | 2020 | 2511 | 0.080 |
Why?
|
| Curriculum | 3 | 2008 | 3718 | 0.080 |
Why?
|
| Diagnosis, Differential | 9 | 2010 | 12965 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6131 | 0.080 |
Why?
|
| Consensus | 1 | 2018 | 3113 | 0.080 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 417 | 0.080 |
Why?
|
| Mandatory Reporting | 1 | 2009 | 124 | 0.080 |
Why?
|
| Efficiency | 1 | 2012 | 477 | 0.080 |
Why?
|
| Mice | 14 | 2008 | 81208 | 0.080 |
Why?
|
| Inflammation | 1 | 2008 | 10756 | 0.080 |
Why?
|
| Serum Albumin | 2 | 1991 | 674 | 0.080 |
Why?
|
| Colon | 3 | 2002 | 1788 | 0.080 |
Why?
|
| Microcirculation | 5 | 2001 | 1278 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 1995 | 1341 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 759 | 0.070 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 250 | 0.070 |
Why?
|
| Benzenesulfonates | 1 | 2008 | 165 | 0.070 |
Why?
|
| Electrophoresis, Disc | 1 | 1987 | 66 | 0.070 |
Why?
|
| Feedback | 1 | 2011 | 791 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2007 | 130 | 0.070 |
Why?
|
| Coronary Disease | 2 | 1995 | 5990 | 0.070 |
Why?
|
| Splanchnic Circulation | 1 | 2007 | 110 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2007 | 190 | 0.070 |
Why?
|
| Triiodobenzoic Acids | 2 | 2011 | 123 | 0.070 |
Why?
|
| Perfusion | 4 | 2008 | 1376 | 0.070 |
Why?
|
| Microbubbles | 1 | 2008 | 128 | 0.070 |
Why?
|
| Fluorescence | 2 | 2007 | 751 | 0.070 |
Why?
|
| Goals | 1 | 2012 | 708 | 0.070 |
Why?
|
| Phlebography | 1 | 2007 | 325 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1739 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2003 | 8552 | 0.060 |
Why?
|
| Liposomes | 4 | 2002 | 777 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 3218 | 0.060 |
Why?
|
| Paracentesis | 1 | 2006 | 98 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2011 | 664 | 0.060 |
Why?
|
| Transducers | 2 | 2004 | 240 | 0.060 |
Why?
|
| Portasystemic Shunt, Surgical | 2 | 1995 | 39 | 0.060 |
Why?
|
| Infection Control | 1 | 2013 | 983 | 0.060 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2005 | 38 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2007 | 341 | 0.060 |
Why?
|
| Cecum | 1 | 2005 | 232 | 0.060 |
Why?
|
| Quality Control | 1 | 2008 | 828 | 0.060 |
Why?
|
| Equipment Safety | 2 | 2003 | 253 | 0.060 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 1200 | 0.060 |
Why?
|
| Fibrinogen | 2 | 1993 | 886 | 0.060 |
Why?
|
| Artifacts | 3 | 2006 | 1898 | 0.060 |
Why?
|
| Information Storage and Retrieval | 2 | 2007 | 822 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 3618 | 0.060 |
Why?
|
| Injections, Intravenous | 6 | 2003 | 1385 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2011 | 2093 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2011 | 1248 | 0.060 |
Why?
|
| Sarcoma, Experimental | 1 | 2004 | 117 | 0.060 |
Why?
|
| Para-Aortic Bodies | 1 | 2003 | 3 | 0.060 |
Why?
|
| Photography | 1 | 2007 | 530 | 0.060 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 2003 | 21 | 0.060 |
Why?
|
| Hemorheology | 1 | 2004 | 144 | 0.060 |
Why?
|
| Regional Blood Flow | 2 | 2004 | 1490 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2007 | 741 | 0.060 |
Why?
|
| Diagnosis | 1 | 2004 | 157 | 0.060 |
Why?
|
| Acetic Acid | 1 | 2003 | 60 | 0.060 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2003 | 45 | 0.060 |
Why?
|
| Drainage | 2 | 2006 | 1161 | 0.050 |
Why?
|
| Diverticulitis | 1 | 2006 | 182 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2005 | 363 | 0.050 |
Why?
|
| Bile | 1 | 2004 | 296 | 0.050 |
Why?
|
| Ascites | 1 | 2005 | 338 | 0.050 |
Why?
|
| Hidrocystoma | 1 | 2002 | 11 | 0.050 |
Why?
|
| Gallbladder | 1 | 2004 | 305 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2004 | 229 | 0.050 |
Why?
|
| Kupffer Cells | 3 | 1998 | 143 | 0.050 |
Why?
|
| Dog Diseases | 1 | 2003 | 141 | 0.050 |
Why?
|
| Gallbladder Neoplasms | 1 | 2004 | 190 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2006 | 1110 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2008 | 542 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Algorithms | 2 | 2017 | 13981 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 707 | 0.050 |
Why?
|
| Phagocytosis | 3 | 1998 | 1535 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1215 | 0.050 |
Why?
|
| Tissue Donors | 2 | 2001 | 2313 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 591 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 292 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2002 | 150 | 0.050 |
Why?
|
| Hemostatic Techniques | 1 | 2002 | 114 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1998 | 8158 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1190 | 0.050 |
Why?
|
| Gallstones | 1 | 2004 | 283 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39261 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2003 | 213 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3465 | 0.050 |
Why?
|
| Bile Duct Diseases | 1 | 2001 | 97 | 0.050 |
Why?
|
| Analgesics | 1 | 2008 | 1065 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5397 | 0.050 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2002 | 117 | 0.050 |
Why?
|
| Injections, Intralesional | 1 | 2001 | 278 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 2001 | 150 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2007 | 763 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2002 | 2234 | 0.040 |
Why?
|
| Practice Management | 1 | 2020 | 37 | 0.040 |
Why?
|
| Microspheres | 1 | 2003 | 787 | 0.040 |
Why?
|
| Emergencies | 1 | 2006 | 1211 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2008 | 936 | 0.040 |
Why?
|
| Glucagon | 1 | 2002 | 532 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 832 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2007 | 15289 | 0.040 |
Why?
|
| Learning Curve | 1 | 2021 | 231 | 0.040 |
Why?
|
| Incidence | 3 | 2020 | 21392 | 0.040 |
Why?
|
| Appendectomy | 1 | 2003 | 431 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 377 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 942 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2004 | 523 | 0.040 |
Why?
|
| Health Services Research | 1 | 2006 | 1810 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2006 | 1168 | 0.040 |
Why?
|
| Endothelium | 1 | 2001 | 764 | 0.040 |
Why?
|
| Anal Canal | 1 | 2001 | 372 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 8035 | 0.040 |
Why?
|
| Hot Temperature | 2 | 2004 | 1435 | 0.040 |
Why?
|
| Portography | 2 | 1995 | 11 | 0.040 |
Why?
|
| Cholelithiasis | 1 | 2000 | 408 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2005 | 1191 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2006 | 760 | 0.040 |
Why?
|
| Autoradiography | 2 | 2002 | 730 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3426 | 0.040 |
Why?
|
| Length of Stay | 2 | 2021 | 6479 | 0.040 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2000 | 231 | 0.040 |
Why?
|
| Ethanol | 2 | 2003 | 1323 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3562 | 0.040 |
Why?
|
| Fatty Liver | 2 | 1994 | 778 | 0.040 |
Why?
|
| Colectomy | 1 | 2003 | 692 | 0.040 |
Why?
|
| Biopsy | 2 | 2006 | 6771 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1023 | 0.040 |
Why?
|
| Cholangiography | 1 | 1997 | 181 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 13308 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 656 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 20080 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 509 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2003 | 4048 | 0.030 |
Why?
|
| Cell Communication | 1 | 2004 | 1653 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2021 | 15697 | 0.030 |
Why?
|
| Abdomen | 1 | 2003 | 1130 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2221 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 983 | 0.030 |
Why?
|
| Mesothelioma | 1 | 2002 | 807 | 0.030 |
Why?
|
| Pyridines | 1 | 2008 | 2879 | 0.030 |
Why?
|
| Prognosis | 4 | 2008 | 29658 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1998 | 226 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2003 | 1479 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2002 | 1189 | 0.030 |
Why?
|
| Cat-Scratch Disease | 1 | 1996 | 23 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2002 | 707 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 74359 | 0.030 |
Why?
|
| Epinephrine | 2 | 2004 | 791 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 1986 | 1423 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6465 | 0.030 |
Why?
|
| Leukocytes | 1 | 2004 | 2026 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 2002 | 650 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1998 | 515 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2004 | 4174 | 0.030 |
Why?
|
| Angina Pectoris | 2 | 1991 | 969 | 0.030 |
Why?
|
| Accident Prevention | 1 | 2015 | 76 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 9287 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1998 | 560 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2004 | 1152 | 0.030 |
Why?
|
| Bronchography | 1 | 1995 | 76 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2512 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 301 | 0.030 |
Why?
|
| Galactans | 1 | 1994 | 31 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 2056 | 0.030 |
Why?
|
| Optics and Photonics | 2 | 2007 | 305 | 0.030 |
Why?
|
| Systems Analysis | 1 | 2015 | 169 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 1925 | 0.030 |
Why?
|
| Indocyanine Green | 2 | 2007 | 236 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2006 | 2147 | 0.030 |
Why?
|
| Pain | 2 | 2006 | 5066 | 0.030 |
Why?
|
| Education, Medical | 1 | 2006 | 1727 | 0.030 |
Why?
|
| Time Factors | 7 | 2006 | 40165 | 0.030 |
Why?
|
| Pentetic Acid | 1 | 1994 | 209 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 2015 | 189 | 0.030 |
Why?
|
| Dogs | 3 | 2004 | 3841 | 0.030 |
Why?
|
| Gallbladder Diseases | 1 | 1995 | 137 | 0.030 |
Why?
|
| Depression, Chemical | 2 | 1991 | 185 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13502 | 0.030 |
Why?
|
| Meglumine | 1 | 1994 | 145 | 0.030 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1993 | 55 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 1995 | 292 | 0.030 |
Why?
|
| Hemorrhage | 2 | 2004 | 3600 | 0.030 |
Why?
|
| Systems Integration | 2 | 2005 | 426 | 0.030 |
Why?
|
| Ebstein Anomaly | 1 | 1994 | 101 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1928 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4000 | 0.030 |
Why?
|
| Varicose Veins | 2 | 1994 | 155 | 0.030 |
Why?
|
| Fistula | 1 | 1995 | 214 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 5130 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 2 | 2003 | 1913 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 168 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8803 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2018 | 54303 | 0.030 |
Why?
|
| Sex Factors | 1 | 2006 | 10547 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 1975 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6238 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2008 | 65017 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2004 | 3539 | 0.020 |
Why?
|
| Hypertension, Portal | 1 | 1993 | 226 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10446 | 0.020 |
Why?
|
| Laparotomy | 2 | 2004 | 465 | 0.020 |
Why?
|
| Physicians | 1 | 2009 | 4591 | 0.020 |
Why?
|
| Sarcoma | 1 | 2002 | 1786 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 1994 | 823 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2002 | 410 | 0.020 |
Why?
|
| Phosphorus | 1 | 1992 | 333 | 0.020 |
Why?
|
| Rats, Inbred ACI | 3 | 1995 | 34 | 0.020 |
Why?
|
| Hemostasis | 1 | 1993 | 468 | 0.020 |
Why?
|
| Nitrogen | 1 | 1992 | 350 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1990 | 56 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1996 | 908 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1994 | 662 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16939 | 0.020 |
Why?
|
| Critical Illness | 1 | 2003 | 2709 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 934 | 0.020 |
Why?
|
| Lung | 2 | 2005 | 9994 | 0.020 |
Why?
|
| Carcinoma | 2 | 2004 | 2331 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 228 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1274 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 18416 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 2943 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3380 | 0.020 |
Why?
|
| Pericardial Effusion | 1 | 1991 | 247 | 0.020 |
Why?
|
| Trachea | 1 | 1995 | 1082 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 1994 | 488 | 0.020 |
Why?
|
| Prealbumin | 1 | 1990 | 222 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1994 | 2025 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2015 | 1183 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1994 | 1431 | 0.020 |
Why?
|
| Scleroderma, Systemic | 1 | 1991 | 344 | 0.020 |
Why?
|
| Diazonium Compounds | 1 | 1987 | 18 | 0.020 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 100 | 0.020 |
Why?
|
| Melanoma | 2 | 2012 | 5697 | 0.020 |
Why?
|
| Back Pain | 1 | 1991 | 543 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 2 | 1997 | 182 | 0.020 |
Why?
|
| Transferrin | 1 | 1988 | 284 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 2418 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 8056 | 0.020 |
Why?
|
| Sodium | 1 | 1992 | 1594 | 0.020 |
Why?
|
| Fibrinolysis | 3 | 1993 | 332 | 0.020 |
Why?
|
| Saliva | 1 | 1991 | 820 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1898 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 866 | 0.020 |
Why?
|
| Niacinamide | 1 | 2008 | 414 | 0.020 |
Why?
|
| Sterilization | 1 | 2006 | 130 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 600 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 81 | 0.020 |
Why?
|
| Electronics | 1 | 2007 | 315 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 1987 | 238 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 1987 | 392 | 0.020 |
Why?
|
| Albumins | 1 | 1988 | 575 | 0.020 |
Why?
|
| Dyspepsia | 1 | 1986 | 118 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2008 | 529 | 0.020 |
Why?
|
| Photomicrography | 1 | 2004 | 71 | 0.020 |
Why?
|
| Cholecystography | 1 | 2004 | 42 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 2 | 1995 | 248 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15840 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2012 | 13262 | 0.010 |
Why?
|
| Mammography | 1 | 2015 | 2427 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 2007 | 542 | 0.010 |
Why?
|
| Gangrene | 1 | 2004 | 91 | 0.010 |
Why?
|
| Adrenergic Agonists | 1 | 2004 | 58 | 0.010 |
Why?
|
| Arsenicals | 1 | 2004 | 117 | 0.010 |
Why?
|
| Graft Survival | 1 | 1994 | 3794 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 239 | 0.010 |
Why?
|
| Mass Screening | 1 | 1999 | 5423 | 0.010 |
Why?
|
| Regression Analysis | 2 | 2004 | 6360 | 0.010 |
Why?
|
| Subcutaneous Tissue | 1 | 2004 | 132 | 0.010 |
Why?
|
| Cell Biology | 1 | 2004 | 90 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 608 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1987 | 926 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1995 | 4563 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1993 | 1931 | 0.010 |
Why?
|
| Reperfusion | 2 | 1994 | 271 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 429 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1818 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 279 | 0.010 |
Why?
|
| Stents | 1 | 1994 | 3314 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 2004 | 406 | 0.010 |
Why?
|
| Permeability | 1 | 2004 | 719 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1995 | 4426 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3765 | 0.010 |
Why?
|
| Military Medicine | 1 | 2003 | 186 | 0.010 |
Why?
|
| Supine Position | 1 | 2002 | 205 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1986 | 679 | 0.010 |
Why?
|
| Apyrase | 1 | 2004 | 373 | 0.010 |
Why?
|
| Academies and Institutes | 1 | 2003 | 319 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 667 | 0.010 |
Why?
|
| Prone Position | 1 | 2002 | 196 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 605 | 0.010 |
Why?
|
| Capillaries | 1 | 2004 | 744 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 777 | 0.010 |
Why?
|
| Organ Preservation | 2 | 1994 | 379 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2004 | 304 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2004 | 442 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2004 | 660 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2003 | 510 | 0.010 |
Why?
|
| Swine | 2 | 2001 | 5899 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 26951 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1832 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5125 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 1456 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 2000 | 99 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 319 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 87810 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2001 | 286 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5799 | 0.010 |
Why?
|
| Adenosine | 1 | 2004 | 834 | 0.010 |
Why?
|
| Protein Binding | 1 | 1991 | 9335 | 0.010 |
Why?
|
| Computer Systems | 1 | 2000 | 470 | 0.010 |
Why?
|
| Budgets | 1 | 2000 | 230 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1998 | 81 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2000 | 713 | 0.010 |
Why?
|
| Kidney | 2 | 2004 | 7064 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2004 | 1207 | 0.010 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 4433 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1993 | 0.010 |
Why?
|
| Science | 1 | 2000 | 239 | 0.010 |
Why?
|
| Tail | 1 | 1997 | 92 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 267 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2221 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1999 | 506 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2298 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10827 | 0.010 |
Why?
|
| Posture | 1 | 2000 | 953 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2668 | 0.010 |
Why?
|
| Bartonella henselae | 1 | 1996 | 15 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1990 | 2859 | 0.010 |
Why?
|
| Awards and Prizes | 1 | 2000 | 359 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4878 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2000 | 805 | 0.010 |
Why?
|
| Ischemia | 1 | 2004 | 1893 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 2932 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4541 | 0.010 |
Why?
|
| Choline Deficiency | 1 | 1994 | 23 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1994 | 64 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 26181 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1995 | 211 | 0.010 |
Why?
|
| Tracheal Diseases | 1 | 1995 | 115 | 0.010 |
Why?
|
| Punctures | 1 | 1995 | 370 | 0.010 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 151 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2002 | 3529 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5870 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 3847 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1995 | 1154 | 0.010 |
Why?
|
| Emulsions | 1 | 1993 | 152 | 0.010 |
Why?
|
| Iopamidol | 1 | 1993 | 186 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2004 | 2520 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1997 | 709 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3484 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3106 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1993 | 278 | 0.010 |
Why?
|
| Adenoma | 1 | 2003 | 2148 | 0.010 |
Why?
|
| Clone Cells | 1 | 1996 | 1660 | 0.010 |
Why?
|
| Methionine | 1 | 1994 | 569 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1995 | 345 | 0.010 |
Why?
|
| Particle Size | 1 | 1996 | 1644 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1992 | 2558 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1991 | 127 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1994 | 901 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9716 | 0.010 |
Why?
|
| Blood Coagulation Factors | 1 | 1993 | 365 | 0.010 |
Why?
|
| Scleroderma, Localized | 1 | 1991 | 87 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 1666 | 0.010 |
Why?
|
| Bronchi | 1 | 1995 | 848 | 0.010 |
Why?
|
| Video Recording | 1 | 1996 | 955 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1990 | 150 | 0.010 |
Why?
|
| Varicose Ulcer | 1 | 1991 | 54 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4166 | 0.010 |
Why?
|
| Densitometry | 1 | 1990 | 151 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1993 | 780 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 1763 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1996 | 3094 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10551 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 660 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 13314 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 2000 | 1469 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7343 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 8555 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1995 | 1273 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2011 | 41335 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 1913 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 4215 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1993 | 1157 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6216 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1995 | 4810 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1987 | 11891 | 0.000 |
Why?
|
| Cell Survival | 1 | 1996 | 5797 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22023 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 2116 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21025 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1996 | 3486 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 4925 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1971 | 2611 | 0.000 |
Why?
|
| Cell Line | 1 | 1996 | 15620 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1971 | 3682 | 0.000 |
Why?
|
| Survival Rate | 1 | 1993 | 12808 | 0.000 |
Why?
|
| Thrombosis | 1 | 1993 | 3052 | 0.000 |
Why?
|
| Palliative Care | 1 | 1993 | 3607 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 9276 | 0.000 |
Why?
|
| Thorium Dioxide | 1 | 1971 | 20 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1971 | 110 | 0.000 |
Why?
|
| Colloids | 1 | 1971 | 122 | 0.000 |
Why?
|
| Histological Techniques | 1 | 1971 | 194 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1971 | 700 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1971 | 1316 | 0.000 |
Why?
|
| Blood Cells | 1 | 1971 | 305 | 0.000 |
Why?
|
| Computers | 1 | 1971 | 595 | 0.000 |
Why?
|